Community SDoH Alert!

RECALL!! POSSIBLE CANCER CAUSING INGREDIENTS IN THE DIABETES DRUG METFORMIN

  • Alert date November 4, 2020

    VISIT WEBSITE

    Covid 19 Related Resource

    METFORMIN – More than 175 different drug combinations have been recalled since late May.

    Kansas City-based Nostrum Laboratories has issued a voluntary recall of two lots of Metformin HCl Extended Release Tablets, USP 750 mg. The addition of Nostrum’s pills come as 76 more lots were flagged in October for a possible cancer-causing ingredient.

    The recall of extended-release metformin continues as two more lots of the diabetes drug have been added to the recall list.

    The FDA announced the previous recall, involving Marksans Pharma Limited and Sun Pharmaceutical Industries products, on Oct. 5. It involves the 500mg and 700mg tablets.

Use the share buttons below to share alert with your community
If you are on a phone use the GREEN SMS button to directly send a text

show translator

AmharicEnglishSomali

COPYRIGHT © 2019 SISTERS IN COMMON